Ellison et al proposed a TNM (Tumor, Node, Metastases) staging scheme for gastrinoma. The authors are from the Ohio State University in Columbus.
Parameters:
(1) diameter of the primary tumor
(2) lymph node metastases
(3) distant metastases
Parameter |
Finding |
Code |
diameter |
primary not found on imaging or at surgery |
T0 |
|
<= 1.0 cm |
T1 |
|
1.1 to 2.0 cm |
T2 |
|
2.1 to 2.9 cm |
T3 |
|
>= 3.0 cm |
T4 |
lymph nodes |
none |
N0 |
|
present |
N1 |
|
cannot be assessed |
Nx |
distant metastases |
none |
M0 |
|
present |
M1 |
|
cannot be assessed |
Mx |
T Status |
N Status |
M Status |
Stage |
T0 |
N0 |
M0 |
0 |
T1 or T2 |
any N |
M0 |
I |
T3 or T4 |
any N |
M0 |
II |
any T |
any N |
M1 |
III |
where:
• The scheme does not cover T0N1MX. In the implementation this is staged as I.
Stage |
20 Year Survival |
0 |
81% |
I |
66% |
II |
52% |
III |
26% |
from Figure 3, page 899
Specialty: Hematology Oncology, Surgery, general, Endocrinology
ICD-10: ,